Status:

COMPLETED

Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients

Lead Sponsor:

NEMA Research, Inc.

Collaborating Sponsors:

Medtronic - MITG

International Clinical Research Institute

Conditions:

Chronic Pain

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

Objective is to evaluate the pharmacokinetics profile of hydrocodone's metabolite hydromorphone in patients who are taking hydrocodone on a routine basis for more than 3 months for chronic pain and co...

Detailed Description

Hydrocodone combinations are the most commonly prescribed pain medications in the United States. All the current available Hydrocodone formulations are short acting and have Acetaminophen/Ibuprofen in...

Eligibility Criteria

Inclusion

  • Man or woman aged 18-75
  • Documented clinical diagnosis of chronic pain.
  • Have been taking hydrocodone/APAP for their chronic non-cancer pain.
  • Subjects currently on hydrocodone/APAP must be taking minimal daily dose of 15mg of Hydrocodone for at least 30 days.
  • Subjects must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.

Exclusion

  • Subjects who are taking concomitant medications or Nutraceuticals that interfere with Hydrocodone metabolism as listed in Appendix 11 and/or as deemed clinically significant by a pharmacovigilance team that is contracted to monitor and advise.
  • Health concerns that the study physician feels may confound study results.
  • Individuals who are cognitively impaired or who are not able to give informed consent.
  • Previous participation in a clinical research trial within 30 days prior to randomization.
  • The subject has an ongoing abuse of illicit substances, alcohol, or actively smoking marijuana.

Key Trial Info

Start Date :

February 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2012

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01517295

Start Date

February 1 2012

End Date

September 1 2012

Last Update

July 28 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

NEMA Research Inc. (CRO)

Naples, Florida, United States, 34108

2

International Clinical Research Institute

Leawood, Kansas, United States, 66211